Results
A total of 123 patients met the inclusion criteria of which, 33 patients (26.8%) had developed and were still affected by post-COVID-19 syndrome 6 months after hospital discharge (Table 1). The univariate analysis shows no statistically significant difference between the use of corticosteroids for patients who have and have not developed post-COVID-19 syndrome (p=0.14). The same results can be seen for patients treated with anticoagulants (p=0.34) or antibiotics (p=0.96) (Table 2).